What is Docetaxel?

Category: Prescription Drugs

Most popular types: Taxotere

false

See also: Docetaxel-carboplatin-trastuzumab-pertuzumab Docetaxel-carboplatin-trastuzumab (TCH) Docetaxel-cyclophosphamide (TC) Docetaxel-doxorubicin-cyclophosphamide (TAC) Docetaxel-trastuzumab-pertuzumab (DHP)

Docetaxel is a chemotherapy agent that can be used to treat a variety of cancers, including breast cancer, non-small cell lung cancer, head and neck cancer, gastrointestinal (stomach) and prostate cancer. This agent may be used alone or in combination with other medications.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Breast cancer 4 0
Prostate cancer 3 3
Adenocarcinoma (non-small cell lung cancer) 2 3
Ovarian cancer 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 2
Moderate 3
Mild 2
None 1

Commonly reported side effects and conditions associated with Docetaxel

Side effect Patients
Brain fog 1
Chronic diarrhea 1
Eyes watering (tearing) 1
Fatigue 1
Hair loss 1
Intestinal cramps 1

Show all 18 reported side effects

Dosages

Based on patients currently taking Docetaxel

Dosage Patients
94.5 mg every 3 weeks 1

Why patients stopped taking Docetaxel

Multiple reasons could be selected

Reason Patients
Course of treatment ended 8
Doctor's advice 2
Did not seem to work 1
See all 10 patients who've stopped taking Docetaxel

Duration

Currently taking Docetaxel

Duration Patients
6 months - 1 year 1
1 - 2 years 1

Stopped taking Docetaxel

Duration Patients
Less than 1 month 1
1 - 6 months 6
6 months - 1 year 3
Adherence
Adherence Evaluations
Always 7
Usually 0
Sometimes 1
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 3
A little hard to take 4
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 6

What people switch to and from

Patients started taking Docetaxel after stopping:

Treatment Patients
Abiraterone (Zytiga) 1
Pemetrexed (Alimta) 1

Patients stopped taking Docetaxel and switched to:

Treatment Patients
Cabazitaxel 1
Gemcitabine (Gemzar) 1
Last updated:

1 patient evaluation for Docetaxel

Oct 6, 2014 (Started Aug 11, 2014)

  • Effectiveness
    Major (for prostate cancer)
  • Side effects
    Mild (nausea)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 40 mg Weekly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Docetaxel